Galena Biopharma (GALE) Announces IDMC Recommendation to Reduce Cardiac Toxicity Monitoring in Phase 3 PRESENT Trial
Tweet Send to a Friend
Galena Biopharma (NASDAQ: GALE) announced that the Independent Data Monitoring Committee (IDMC) has recommended to the Company that it can ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE